Further characterization of specific drug binding sites on human serum albumin

G. Sudlow, D. J. Birkett, D. N. Wade

Research output: Contribution to journalArticlepeer-review

1477 Citations (Scopus)


The fluorescent probes 5 dimethylaminonaphthalene 1 sulfonamide and dansylsarcosine function as specific markers for two distinct binding sites for anionic drugs on human serum albumin (HSA). The binding of drugs to site I or II was detected by measuring the displacement of these probes. The results give an indication of some of the structural features required for binding at these sites. Stearic acid binding to HSA induced different conformational changes in the albumin at sites I and II, which were detected by changes in the fluorescence and/or strength of binding of probes specific for the two sites. This provides further evidence for qualitative differences between the two sites. The specificity of the sites for particular drugs, even at high drug to albumin ratios, was established, and the specificity and characteristics of the two sites on human adult and neonatal sera were shown to be similar to those on crystalline HSA.

Original languageEnglish
Pages (from-to)1052-1061
Number of pages10
JournalMolecular Pharmacology
Issue number6
Publication statusPublished - Nov 1976
Externally publishedYes


Dive into the research topics of 'Further characterization of specific drug binding sites on human serum albumin'. Together they form a unique fingerprint.

Cite this